Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of TAT Technologies Ltd. due to recent disclosures regarding supply chain disruptions that may have led to investor losses [1][3][4]. Group 1: Company Financial Performance - On March 18, 2026, TAT Technologies Ltd. reported its fourth quarter and full year 2025 financial results [3]. - During the earnings call on March 19, 2026, TAT disclosed experiencing "another wave of supply chain disruptions" in Q4 2025, which continued into Q1 2026 [3]. - The company acknowledged delays in parts availability from a major supplier, affecting APU and landing gear service turnaround times, and warned of ongoing operational challenges [3]. Group 2: Investor Impact - Following the disclosures about supply chain issues, TAT Technologies' stock price declined, resulting in losses for investors [3]. - Johnson Fistel is investigating whether TAT Technologies complied with federal securities laws in light of these disclosures [4]. Group 3: Legal Representation - Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm that represents individual and institutional investors in securities class action lawsuits [5]. - The firm has a history of recovering significant amounts for clients, with approximately $90,725,000 recovered in 2024 [6].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Kopin Corporation due to concerns regarding the company's compliance with federal securities laws following a delay in filing its Annual Report [1][3]. Group 1: Investigation Details - The investigation is focused on Kopin's executive officers and whether investor losses may be recoverable under federal securities laws [1]. - On March 27, 2026, Kopin filed a Form NT-10K with the U.S. Securities and Exchange Commission, indicating it was unable to timely file its Annual Report due to "complex technical accounting considerations" [3]. - The issues cited by Kopin include problems related to "recognition, measurement, presentation, and related valuations" [3]. Group 2: Investor Information - Investors who purchased Kopin securities and suffered losses are encouraged to join the investigation, with no cost or obligation [2]. - For further information, investors can contact Jim Baker at Johnson Fistel [2]. Group 3: Johnson Fistel Overview - Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm with multiple offices across the United States [4]. - The firm has a track record of representing individual and institutional investors in shareholder derivative and securities class action lawsuits [4]. - In 2024, Johnson Fistel was ranked among the Top 10 Plaintiff Law Firms, recovering approximately $90,725,000 for clients in cases where it served as lead or co-lead counsel [5].

Core Viewpoint - Halper Sadeh LLC is investigating whether Centessa Pharmaceuticals plc is obtaining a fair price for its shareholders in the proposed sale to Eli Lilly and Company for $38.00 in cash per share plus a contingent value right worth up to $9.00 based on certain milestones [3]. Group 1: Investigation Details - The investigation focuses on whether Centessa and its board violated federal securities laws and/or breached fiduciary duties by failing to secure the best possible price for shareholders, conduct a fair sales process, and disclose all material information necessary for shareholders to evaluate the transaction [5]. - The proposed transaction may include terms that could limit superior competing offers, potentially disadvantaging ordinary shareholders [1]. Group 2: Shareholder Rights - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their rights and options at no cost, with the firm operating on a contingent fee basis [2][4]. - Halper Sadeh LLC may seek increased consideration, additional disclosures, or other relief and benefits on behalf of shareholders [6].

Core Viewpoint - The Schall Law Firm is investigating potential securities law violations by Walker & Dunlop, Inc., focusing on whether the company made false or misleading statements that affected investors [1][2]. Financial Performance - Walker & Dunlop reported Q4 2025 financial results on February 26, 2026, with adjusted earnings per share falling short of consensus estimates by nearly 81% [2]. - Following the disappointing earnings report, shares of Walker & Dunlop dropped by over 19.4% on the same day [2]. Legal Action - The Schall Law Firm is inviting shareholders who suffered losses to participate in the investigation and potentially join a class action lawsuit [1][2]. - Investors can contact the Schall Law Firm for a free discussion regarding their rights [3].

Core Viewpoint - On Holding AG is under investigation for potential violations of securities laws, following the announcement of CEO Martin Hoffmann's planned departure, which led to a significant drop in share price [2]. Group 1: Company Developments - On Holding AG announced that CEO Martin Hoffmann will step down in May 2026 to pursue charitable interests, with co-founders taking over as co-CEOs [2]. - The announcement of Hoffmann's departure resulted in a nearly 11.2% decline in On Holding AG's share price on the same day [2]. Group 2: Legal Actions - The Schall Law Firm is investigating claims on behalf of investors regarding false or misleading statements made by On Holding AG [2]. - Shareholders who have suffered losses are encouraged to participate in the investigation and can contact the Schall Law Firm for more information [3].

Core Viewpoint - The Schall Law Firm is investigating Vertical Aerospace Ltd. for potential violations of securities laws, particularly focusing on misleading statements and undisclosed information that may have affected investors [1][2]. Group 1: Company Financials and Concerns - Vertical Aerospace filed its annual report for 2025 with the SEC on March 24, 2026, indicating significant financial concerns, including limited cash, recurring operational losses, and a dependency on raising additional capital, which raises doubts about the company's ability to continue as a going concern [2]. - Following the release of this report, shares of Vertical Aerospace fell by nearly 18.2% on the same day, reflecting investor reaction to the disclosed financial uncertainties [2]. Group 2: Legal Actions and Investor Opportunities - The Schall Law Firm is inviting shareholders who have suffered losses to participate in the investigation and discuss their rights [3]. - The firm specializes in securities class action lawsuits and shareholder rights litigation, indicating a focus on protecting investor interests [3].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of X Financial due to significant financial losses reported by the company [1][4]. Financial Performance - X Financial reported a total net revenue decrease of 14.1% year-over-year and 25.1% quarter-over-quarter for the fourth quarter and full year 2025 [3]. - The company's net income declined by 85.2% year-over-year, indicating severe profitability issues [3]. Loan Delinquency Rates - The investigation highlights an increase in loan delinquency rates, with loans 31–60 days past due rising to 2.90% from 1.17% and loans 91–180 days past due increasing to 6.31% from 2.48% [3]. Asset Quality and Profitability - X Financial stated that "asset quality came under increased pressure," which significantly impacted profitability due to higher credit-related provisions [3].

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Lumexa Imaging Holdings, Inc. due to significant losses following the company's financial disclosures [1][3][4] Group 1: Investigation Details - The investigation focuses on whether Lumexa Imaging's executive officers complied with federal securities laws after the company reported a net loss for both the fourth quarter and full year of 2025 [1][3] - Following the financial results announcement on March 26, 2026, Lumexa Imaging's stock price experienced a significant decline [3] Group 2: Investor Information - Investors who purchased Lumexa Imaging securities and suffered losses are encouraged to join the investigation, with no cost or obligation [2] - For further information, investors can contact Jim Baker at Johnson Fistel [2]

Core Viewpoint - Holzer & Holzer, LLC is investigating ADMA Biologics, Inc. for potential violations of federal securities laws following allegations of inflated revenue growth due to channel stuffing practices [1] Company Investigation - Culper Research published a report claiming that ADMA's reported revenue growth of +20% in 2025 was misleading, estimating that actual revenues declined by 3% when excluding channel stuffing [1] - The report has led to a decline in ADMA's stock price, indicating market reaction to the allegations [1] Legal Context - Shareholders who purchased ADMA stock and incurred losses are encouraged to contact Holzer & Holzer for legal representation regarding their rights [2] - Holzer & Holzer is recognized as a top-rated securities litigation law firm, focusing on shareholder and investor representation in cases of corporate misconduct [3]

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of MillerKnoll, Inc. due to losses that may be recoverable under federal securities laws following disappointing financial results and guidance [1][4]. Financial Performance - MillerKnoll reported adjusted earnings per share of $0.43 and net sales of approximately $926.6 million for the third quarter of fiscal 2026, both figures falling below analyst expectations [3]. - The company provided fourth quarter guidance indicating net sales between approximately $955 million and $995 million and adjusted earnings per share between $0.49 and $0.55, which are also below consensus estimates [3]. Market Impact - Following the financial disclosures, MillerKnoll's stock price declined approximately 19% [4]. - The company noted a slowdown in showroom visits and lower retail traffic, attributed in part to severe weather conditions [3]. Operational Challenges - MillerKnoll expects to ship only a minimal amount of approximately $12 million in Middle East-related orders in the fourth quarter, with the ongoing conflict anticipated to have a direct impact of approximately $8 million to $9 million [3].